BlackRock Fund Advisors’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

BlackRock Fund Advisors’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$185K	Buy	33,080 +4,851	+17%	+$26.6K	﹤0.01%	3441
2016 Q3	$157K	Sell	28,229 -63	-0.2%	-$417	﹤0.01%	3528
2016 Q2	$198K	Buy	28,292 +3,639	+15%	+$25.6K	﹤0.01%	3455
2016 Q1	$163K	Sell	24,653 -1,932	-7%	-$14.2K	﹤0.01%	3542
2015 Q4	$274K	Buy	26,585 +1,222	+5%	+$14.2K	﹤0.01%	3414
2015 Q3	$299K	Sell	25,363 -672	-3%	-$7.43K	﹤0.01%	3337
2015 Q2	$238K	Sell	26,035 -299	-1%	-$2.26K	﹤0.01%	3459
2015 Q1	$164K	Sell	26,334 -2,005	-7%	-$12.4K	﹤0.01%	3529
2014 Q4	$159K	Buy	28,339 +2,016	+8%	+$11.7K	﹤0.01%	3541
2014 Q3	$155K	Sell	26,323 -1,914	-7%	-$11.7K	﹤0.01%	3555
2014 Q2	$193K	Buy	+28,237	New	+$189K	﹤0.01%	3502

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

BlackRock Fund Advisors's JNP Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Juniper Pharmaceuticals, Inc. Common Stock (JNP) stake by 17% in Q4 2016, buying an estimated $26.6K and bringing the position to 33,080 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #3441.

BlackRock Fund Advisors first reported a position in JNP in Q2 2014 and has held it in 11 quarters since. The position peaked at $299K in Q3 2015. 40 funds tracked by Wall St. Rank hold JNP as of Q4 2016.

BlackRock Fund Advisors held 33,080 shares of Juniper Pharmaceuticals, Inc. Common Stock worth $185K as of Q4 2016.
BlackRock Fund Advisors bought 4,851 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2016, an estimated $26.6K.
Juniper Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3441 holding.
BlackRock Fund Advisors first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2014 and has held it in 11 quarters since.
BlackRock Fund Advisors's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $299K in Q3 2015.
40 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.